Total Payments
$314.22
2022 Payments
$61.90
Companies
8
Transactions
15
Medicare Patients
1,074
Medicare Billing
$107,272
Payment Breakdown by Category
Food & Beverage$314.22 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $314.22 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $74.36 | 3 | $0 (2018) |
| Boston Scientific Corporation | $62.97 | 2 | $0 (2020) |
| ABBVIE INC. | $49.23 | 3 | $0 (2022) |
| Wilson Cook Medical Incorporated | $40.80 | 1 | $0 (2017) |
| Takeda Pharmaceuticals U.S.A., Inc. | $35.98 | 2 | $0 (2022) |
| QOL Medical, LLC | $22.80 | 2 | $0 (2020) |
| Braintree Laboratories, Inc. | $15.62 | 1 | $0 (2022) |
| Intercept Pharmaceuticals, Inc. | $12.46 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $61.90 | 3 | ABBVIE INC. ($24.47) |
| 2021 | $27.48 | 2 | Takeda Pharmaceuticals U.S.A., Inc. ($14.17) |
| 2020 | $75.96 | 3 | Boston Scientific Corporation ($51.69) |
| 2019 | $22.27 | 2 | Boston Scientific Corporation ($11.28) |
| 2018 | $24.78 | 1 | PFIZER INC. ($24.78) |
| 2017 | $101.83 | 4 | PFIZER INC. ($49.58) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Braintree Laboratories, Inc. | SUTAB (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: GI COLON PREP | ||||||
| 01/27/2022 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/26/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/18/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/14/2021 | AbbVie Inc. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2020 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
| 07/28/2020 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $11.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 03/10/2020 | Boston Scientific Corporation | GENERAL - BIOPSY (Device) | Food and Beverage | In-kind items and services | $51.69 | General |
| Category: BIOPSY | ||||||
| 08/22/2019 | Boston Scientific Corporation | GENERAL BIOPSY (Device) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: BIOPSY | ||||||
| 08/21/2019 | QOL Medical, LLC | Sucraid (Drug) | Food and Beverage | Cash or cash equivalent | $10.99 | General |
| Category: THERAPY FOR CSID | ||||||
| 04/05/2018 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: INFLAMMATION | ||||||
| 05/09/2017 | PFIZER INC. | INFLECTRA | Food and Beverage | In-kind items and services | $24.79 | General |
| 04/24/2017 | PFIZER INC. | INFLECTRA (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: INFLAMMATION | ||||||
| 04/18/2017 | Wilson Cook Medical Incorporated | Cook Medical Hemostasis (Device) | Food and Beverage | Cash or cash equivalent | $40.80 | General |
| Category: Endoscopy | ||||||
| 02/09/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $11.45 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 104 | 109 | $26,802 | $9,404 |
| 2022 | 11 | 282 | 304 | $242,072 | $30,376 |
| 2021 | 11 | 262 | 305 | $180,047 | $26,221 |
| 2020 | 13 | 426 | 519 | $288,185 | $41,271 |
Total Patients
1,074
Total Services
1,237
Medicare Billing
$107,272
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,194 | $2,475 | 34.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 16 | 17 | $6,392 | $2,308 | 36.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,620 | $1,473 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $3,542 | $1,454 | 41.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 14 | $3,626 | $925.18 | 25.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 14 | $1,428 | $768.74 | 53.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 66 | 66 | $95,207 | $12,612 | 13.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 39 | 40 | $41,503 | $3,276 | 7.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $18,029 | $3,035 | 16.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 35 | 35 | $30,250 | $2,756 | 9.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 11 | 11 | $11,684 | $1,957 | 16.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 31 | 51 | $4,131 | $1,460 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 20 | $3,952 | $1,432 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,972 | $1,161 | 39.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $2,580 | $1,113 | 43.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 19 | 19 | $23,850 | $933.58 | 3.9% |
| 43450 | Dilation of esophagus | Facility | 2022 | 22 | 22 | $7,914 | $640.80 | 8.1% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 49 | 50 | $70,000 | $9,476 | 13.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 21 | 21 | $21,000 | $3,794 | 18.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 24 | $4,440 | $2,406 | 54.2% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 26 | 28 | $22,400 | $2,387 | 10.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 44 | 73 | $11,680 | $1,789 | 15.3% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 22 | 22 | $22,000 | $1,538 | 7.0% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 14 | 14 | $16,800 | $1,471 | 8.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $2,365 | $1,158 | 49.0% |
About Dr. Lee Hixson, M.D
Dr. Lee Hixson, M.D is a Gastroenterology healthcare provider based in Lewiston, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1952314593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lee Hixson, M.D has received a total of $314.22 in payments from pharmaceutical and medical device companies, with $61.90 received in 2022. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($314.22).
As a Medicare-enrolled provider, Hixson has provided services to 1,074 Medicare beneficiaries, totaling 1,237 services with total Medicare billing of $107,272. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Lewiston, ID
- Active Since 08/14/2006
- Last Updated 09/16/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1952314593
Products in Payments
- GENERAL - BIOPSY (Device) $51.69
- INFLECTRA (Biological) $49.57
- Cook Medical Hemostasis (Device) $40.80
- ENTYVIO (Biological) $35.98
- CREON (Drug) $24.47
- Sucraid (Drug) $22.80
- SUTAB (Drug) $15.62
- HUMIRA (Biological) $13.31
- OCALIVA (Drug) $12.46
- Humira (Biological) $11.45
- GENERAL BIOPSY (Device) $11.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lewiston
Dr. Oswaldo Bisbal, Md, MD
Gastroenterology — Payments: $3,688
Gastroenterology $3,688
Dr. Benjamin Stein, M.d.,, M.D.,
Gastroenterology — Payments: $3,409
Gastroenterology $3,409
Emil Miskovsky, Md, MD
Gastroenterology — Payments: $2,859
Gastroenterology $2,859
Dr. Winoah Henry, M.d, M.D
Gastroenterology — Payments: $1,659
Gastroenterology $1,659
Catherine Mccrann, Md, MD
Gastroenterology — Payments: $910.59
Gastroenterology $910.59
Dr. Mark Branda, Md, MD
Gastroenterology — Payments: $559.13
Gastroenterology $559.13